A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT03441555 · COMPLETED
Trial details
- NCT number
- NCT03441555
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-30
- Primary completion
- 2021-01-25
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.